Sharps Technology Inc., a Nasdaq-listed medical device firm, has priced an over $400 million private investment in public equity to fund a new digital asset treasury built around Solana’s native token, SOL. The company said the transaction, structured at $6.50 per unit and stapled with three-year warrants exercisable at $9.75, is slated to close on or about Aug. 28, subject to customary conditions. Proceeds will be used chiefly to accumulate SOL and establish on-chain treasury operations that the company expects to generate roughly 7% staking yield, with remaining funds earmarked for working capital. Sharps also signed a non-binding letter of intent with the Solana Foundation to purchase $50 million worth of SOL at a 15% discount to the 30-day time-weighted average price, contingent on the completion of a future public offering. The PIPE drew participation from digital-asset specialists and traditional investors including ParaFi Capital, Pantera Capital, Monarq and FalconX. News of the deal sent Sharps Technology’s shares more than 50% higher in pre-market trading, highlighting investor appetite for corporate crypto-treasury plays even as the company continues to market its smart-safety syringe products.